MeiraGTx Holdings plc's (NASDAQ:MGTX) Shift From Loss To Profit - simplywall.st
2 weeks ago • Google News
MeiraGTx Holdings PLC (MGTX)
US$ 6.415.08%
Price Chart
Key Statistics
Market Cap
$ 449.33M
P/E Ratio
0.00
Revenue (TTM)
$ 33.28M
Volume
272.03K
52W High
$ 8.75
52W Low
$ 3.85
Dividend Yield
0.00%
Beta
1.31
Technicals
50-Day MA
6.5703
200-Day MA
5.7547
52 Week High
8.75
52 Week Low
3.85
About MGTX
MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, in.
Employees
375
Headquarters
New York, NY
CEO
Dr. Alexandria Forbes Ph.D.
Latest News
MeiraGTx (MGTX) Gains RMAT Designation for Parkinson's Treatment - GuruFocus
3 days ago • Google News
MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future - Yahoo Finance
2025-03-24 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg